BACKGROUND: Misoprostol is effective for cervical priming prior to suction evacuation in first trimester pregnancy termination. This is the first randomized study to compare vaginal misoprostol versus expectant treatment in women presenting with spontaneous miscarriage. METHODS: Sixty women presenting with spontaneous miscarriage were recruited to the study at the Queen Mary Hospital between 1998 and 1999. They were randomized to group 1: misoprostol; and group 2: expectant management. Women in the misoprostol group received vaginal misoprostol 400 µg on days 1, 3 and 5. The expectant group was followed up according to the same schedule. Suction evacuation was performed if there was excessive bleeding or abdominal pain; or if a gestational sac was detected by transvaginal scan on day 15. RESULTS: Fifty-nine women completed the trial. Those who did not require suction evacuation up to the time of return of normal menstruation were considered to be successful. The incidence of side-effects was comparable between the two groups. Three women in the expectant group and one in the misoprostol group underwent emergency suction evacuation because of excessive bleeding. The mean duration of vaginal bleeding was similar for both groups (14.6 days in the misoprostol group versus 15.0 days in the expectant group). The successful rate in the misoprostol group was significantly higher than that of the expectant group (83.3 versus 48.3%, P < 0.05). CONCLUSION: We recommend repeated vaginal misoprostol 400 µg given on days 1, 3 and 5 as a treatment option for women with first trimester spontaneous miscarriage.
Introduction
and may be able to generate cost savings when compared with surgical management (Huges et al., 1996) . The need for routine Spontaneous miscarriage occurs in about 14-19% of clinical suction evacuation is thus being questioned. pregnancies (Laferia, 1986; Hammerslough, 1992) . Over the Misoprostol, a synthetic prostaglandin oestrone analogue, past 50 years, suction evacuation has been the conventional has been shown to be effective for cervical priming prior to method of treatment. The aim is to evacuate the uterus as soon suction evacuation in first trimester pregnancy terminations as possible to decrease the risk of infection. Nowadays, (Ngai et al., 1999) . However, data from randomized trials diagnosis of early pregnancy failure is made possible by comparing expectant versus repeated vaginal misoprostol for improvements in ultrasound imaging, which may have resulted spontaneous abortion are lacking. We therefore performed a in an increase in the number of suction evacuations performed. randomized study to investigate its role in the management of However, this procedure is not without risks. It may be first trimester spontaneous miscarriage. associated with cervical injury, uterine perforation, pelvic infection and excessive bleeding. The overall complication Materials and methods rate varies between 4 and 10% (Farell et al., 1982; Heisterberg Ethical approval for the study was granted by the Ethics Committee, et al., 1986) .
Queen Mary Hospital, Hong Kong. A total of 60 women with a Recently, alternative treatment approaches have been sugclinical diagnosis of spontaneous miscarriage were recruited. All gave gested. There is evidence that a substantial proportion of informed consent after the study had been explained, including their spontaneous miscarriage will resolve spontaneously (Letterie right to withdraw from the trial at any time without prejudice to their et al., 1991) . Furthermore, medical treatment using prostasubsequent medical care. All women satisfied the following criteria: glandin analogues and antiprogesterone have been shown to (i) Ͼ16 years old; (ii) good past health; (iii) positive pregnancy test; be effective in the management of spontaneous miscarriage (iv) gestation age ഛ12 weeks; (v) ultrasound confirmed the diagnosis (Henshaw et al., 1993; Chung et al., 1995; Nielsen and Hahlin, of missed miscarriage (Bernard and Cooperberg, 1985) : (a) intrauterine gestational sac with a mean sac diameter of ജ2 cm without fetal 1995). Medical management was also found to be effective pole; (b) presence of fetal pole with no cardiac pulsation; (c) the Women were randomized into two groups: group 1: misoprostol treatment; group 2: expectant treatment.
Data are expressed as mean (SD) for age, weight and menstrual delay. For other parameters, percentages are shown in parenthesis.
Medical treatment
TOP ϭ termination of pregnancy, USG ϭ ultrasonography.
In our previous study, we have shown that the vaginal route was a P Ͻ 0.05.
more effective and the incidence of side-effects was lower when compared with the oral route in second trimester termination of classified as successful cases. Failure was defined as the recourse to pregnancy (Ho et al., 1997) . Therefore the vaginal route was used in surgical treatment either due to method failure or change of patients' this study. As we were planning a protocol that could be managed in decision. The incidences of side-effects, duration of vaginal bleeding, an out-patient setting, side-effects such as excessive vaginal bleeding dosage of analgesic requirement and infection rate between the two and gastro-intestinal upset leading to emergency admission should be groups were also compared. Standardized questionnaires were given avoided. Chung et al. (1999) used the daily dose of 1200 µg to patients during and after the abortion in order to assess patients' misoprostol for the management of spontaneous miscarriage (Chung acceptability and the incidence of side-effects. et al., 1999) . In order to minimize the incidence of side-effects, we
The calculation of the sample size was based on the following decided to use a lower daily dose (400 µg) and give it every other assumptions: (i) type 1 error of 0.05 and power of 0.85 were day. The day of diagnosis and recruitment was defined as day 0. On acceptable; (ii) the use of misoprostol would achieve a complete day 1, women were given 400 µg vaginal misoprostol followed by a abortion rate of 60% (Chung et al., 1995) so that it could be clinically 4 h clinical observation period (hourly recording of blood pressure, useful as an alternative when compared with surgical intervention. pulse rate and the amount of oral analgesia given) in the day care
The chance of spontaneous resolution in the expectant group was centre. Expulsion of gestational products, where present, was recorded about 20%. Assuming that 10% of the data were retrospectively on the data forms. Side-effects such as nausea, vomiting and abdominal excluded due to incomplete data, the number was 29 in each group. pain were also recorded. Patients were discharged if there was Thus, the total required sample size was 58. The differences of no excessive vaginal bleeding. Emergency suction evacuation was discrete variables were analysed by χ 2 test or Fisher's exact test. The arranged where excessive blood loss or abdominal pain occurred.
differences of continuous variables were analysed by the Student's The decision for emergency suction evacuation was made by the ont-test for normally distributed data and Mann-Whitney's U-test for call medical officer based on clinical judgement. The amount of skewed data. blood loss was assessed clinically by the on-call doctor. Objective measurement of blood loss was not done. All women were advised to record and bring the tissue mass back if it was passed at home.
Results
Oral analgesia was given and the dosage and frequency of medication A total of 60 women were recruited to this study. One patient taken were recorded. Sexual intercourse was avoided in the following in the expectant group was excluded from analysis. This patient 2 weeks. The same procedure was repeated on day 3 and day 5. was recruited in error because an ultrasound scan showed that the fetal parameter was Ͼ13 weeks gestation. She subsequently Table I . The percentage of women who had a bleeding. They were advised to come back if excessive bleeding was noted. They were then followed up on day 3 and day 5. If they had previous termination of pregnancy was significantly higher in passed tissue masses, transvaginal ultrasonography was performed to the misoprostol group (46.7 versus 20.0%, P ϭ 0.03). Other check for retained gestational product. demographic characteristics were comparable between the two groups.
Outcome assessment
The incidences of side-effects were comparable between
The initial judgement about the outcome was made on day 15. If the both groups (Table II) . Nausea and vomiting were common ultrasound findings were compatible with a missed miscarriage but considered as tolerable and transient. The number of (identifiable gestational sac without fetal heart activity), suction women who had no side-effects was similar between the two evacuation was performed and the aspirates were sent for histological groups (eight in the misoprostol group versus nine in the examination. If the ultrasound findings were compatible with complete expectant group). There was no significant difference between or incomplete miscarriage, no further action was taken. All women the two groups in the proportion of women having one or were followed up on day 43. If menstruation did not return, an more side-effects (73.3% in misoprostol group versus 69.0% additional follow-up visit was arranged. Those who did not require suction evacuation up to the time of normal menstruation were in expectant group). Three women in the expectant group and
Misoprostol and spontaneous miscarriage
The mean duration of vaginal bleeding was similar between (83.3% in misoprostol versus 17.1% in placebo), when given 1 day prior to suction evacuation for missed miscarriage. However, transvaginal scans were not repeated prior to the ive when compared with expectant management.
incomplete miscarriage at initial presentation 5/5 (100) 8/10 (80) Nielsen et al. (1999) the drug costs of the regimen. We demonstrated that by using vaginal misoprostol alone, the successful rate was comparable with the combination of mifepristone and misoprostol. Patients one in the misoprostol group underwent emergency suction evacuation because of excessive bleeding. None of them can have an option of medical treatment where mifepristone is not available. required blood transfusion.
The outcome of treatment is shown in Table III . The complete Chung et al. (1999) had compared oral misoprostol versus surgical treatment in a randomized trial (Chung et al., 1999) . abortion rate in the misoprostol group was significantly higher than in the expectant group (83.3 versus 48.3%, P Ͻ 0.05).
In their study, women who presented with the clinical diagnosis of spontaneous miscarriage were recruited. Those who preThe breakdown of failure cases according to the classification of Winikoff et al. (1996) was as follows: (i) method failure:
sented with ultrasound scan findings showing a choriodecidual reaction measuring Ͻ5 cm 2 in transverse and Ͻ6 cm 2 in the seven women in the expectant group and two in the misoprostol group; (ii) woman's own decision: five in the expectant group sagittal plane were considered to have an empty uterus and were excluded from the trial. In their study, the successful rate and two in the misoprostol group; (iii) doctor's decision: three in the expectant group and one woman in the misoprostol of misoprostol treatment was 50.4%. Women treated with misoprostol had significantly more blood loss and required group had an emergency operation because of excessive bleeding.
more analgesia when compared with the surgical group. Seven subjects in the misoprostol group failed to complete the We recruited those presenting with missed miscarriage and incomplete miscarriage because both groups required suction protocol because of excessive side-effects. In our study, all women considered the side-effects tolerable and transient. evacuation according to our usual treatment protocol. The chance of the incomplete miscarriage group not requiring Only one patient in the misoprostol group underwent emergency suction evacuation because of excessive bleeding. Our suction evacuation was higher than that of the missed miscarriage. The fact that more patients presenting with a missed complete miscarriage rate (83.3%) is also higher. This is probably due to the difference in administration route and the miscarriage were included in the misoprostol group than the expectant group (83.3 versus 63.3%) suggested that the actual dosage of treatment protocol. They used oral misoprostol 400 µg every 4 h up to a total dose of 1200 µg, whereas in clinical benefit from the former was likely to be larger than that which has been demonstrated by this study.
our study, we were using a lower daily dosage (400 µg)
